Skip to content
PIL Logo

Atimos Modulite 12 micrograms inhaler

Last Updated on eMC 21-Oct-2015 View changes  | Chiesi Limited Contact details

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Text only version for the visually impaired
Below is a text only representation of the Patient Information leaflet. The original may contain images or tables and can be viewed in PDF format using the link to the left. This PIL may be available from the RNIB in large print, Braille or audio CD. For further information please call the RNIB Medicine Leaflet line on 0800 198 5000. The product code(s) for this leaflet is/are: PL 08829/0154.



Atimos Modulite 12 micrograms inhaler

PACKAGE LEAFLET: INFORMATION FOR THE USER

Atimos® Modulite® 12 micrograms/actuation pressurised inhalation solution

Formoterol fumarate dihydrate

Read all of this leaflet carefully before you start using this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor, or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them even if their symptoms are the same as yours.
  • If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

In this leaflet:

1. What Atimos Modulite is and what it is used for
2. Before you use Atimos Modulite
3. How to use Atimos Modulite
4. Possible side effects
5. How to store Atimos Modulite
6. Further information

1. What Atimos Modulite is and what it is used for

Atimos Modulite is an inhalation medicine delivering its active ingredient directly into your lungs where it is needed. It is used to treat the symptoms of wheezing and breathlessness in patients with moderate to severe asthma. Its active ingredient, formoterol fumarate, belongs to a group of medicines called bronchodilators: they make breathing easier by relaxing muscle spasms in the air passages of the lungs. Regular use of Atimos Modulite together with steroids (either by inhaler or by mouth), will help to prevent breathing problems over the long term.

Atimos Modulite can also be used for the relief of symptoms such as cough, wheezing and shortness of breath in patients with chronic obstructive pulmonary disease (COPD) who require long-term regular bronchodilator therapy.

2. Before you use Atimos Modulite

Do not use Atimos Modulite:

  • if you are allergic to formoterol or to any of the ingredients of Atimos Modulite.
  • to treat a sudden attack of breathlessness. It will not help. Use a reliever for this purpose and carry it with you at all times.

Take special care with Atimos Modulite and always tell your doctor if you:

  • suffer from severe heart disease, especially a recent heart attack, a disease of the coronary vessels of the heart or severe weakness of the heart muscle (congestive heart failure)
  • suffer from disorders of heart rhythm such as increased heart rate, heart valve defect or certain electrocardiogram abnormalities or any other heart disease
  • have narrowing of the blood vessels, especially the arteries, or abnormal widening of the vessel wall
  • suffer from high blood pressure
  • have high sugar levels in the blood (diabetes mellitus)
  • have low blood potassium levels
  • have an overactive thyroid gland
  • are suffering from epinephrine and nor-epinephrine producing tumours of the adrenal medulla
  • are going to have any surgery or receive halogenated anaesthetics

Taking other medicines:

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines including medicines obtained without prescription.

Some medicines may interfere with the action of Atimos Modulite, these include medicines:

  • for treating abnormal heart rhythms (for example quinidine, disopyramide, procainamide)
  • for treating heart disease (for example digitalis)
  • for treating nasal congestion (for example ephedrine)
  • called beta adrenergic blockers used to treat heart conditions or glaucoma (an increase of the pressure in the eye), as tablets or eye drops
  • containing erythromycin (used to treat infections)
  • for treating symptoms of depression: monoamine oxidase inhibitors (for example phenelzine and isocarboxazid) or tricyclic antidepressants (for example amitryptiline and imipramine)
  • to treat severe mental disorders (for example chlorpromazine and trifluperazine)
  • used to treat allergic reactions (such as anti-histamines, for example terfenadine, astemizole, mizolastine)
  • used to treat bronchial asthma (for example theophylline, aminophylline or steroids)
  • used to increase urine production (such as diuretics)
  • for treating Parkinsonism (for example levodopa)
  • containing oxytocin, which causes uterus contraction.
  • to treat an underactive thyroid gland (for example thyroxine)

The addition of anticholinergics (such as tiotropium or ipratropium bromide) to the treatment with Atimos Modulite can help to open your airways even more.

Other special warnings:

  • You have also been prescribed corticosteroids for your breathing problems. It is very important to keep using these regularly. Do not stop using them or change the dose when you start using Atimos Modulite.

Pregnancy and breast feeding:

If you are pregnant or breast-feeding, or could become pregnant, talk to your doctor before using Atimos Modulite.

The use of Atimos Modulite during pregnancy is only indicated if absolutely necessary.

If you are breast-feeding, talk to your doctor before using Atimos Modulite.

Driving and using machines:

Atimos Modulite is unlikely to have any effect on the ability to drive and operate machinery.

Important information about some of the ingredients of Atimos Modulite:

Atimos Modulite contains a small amount of alcohol: each puff of your inhaler contains about 9 mg of ethanol.

3. How to use Atimos Modulite

Dosage:

For Asthma:

The dose of Atimos Modulite you must inhale will depend on the type of asthma you have and how severe it is. Your dose will be decided by your doctor and it is important that you only take the prescribed dose, regularly.

The usual dose for adults, including the elderly and adolescents 12 years and older is 1 puff in the morning and 1 puff in the evening. This means you need to take a total of 2 puffs (24 micrograms) of Atimos Modulite per day.

If you suffer from more severe asthma your doctor may prescribe 4 puffs per day (48 micrograms), 2 puffs in the morning and 2 puffs in the evening.

4 puffs (48 micrograms) of Atimos Modulite is the maximum daily dose and it is important that you do not take more than the total daily dose that your doctor has told you to take.

This product is not suitable for asthmatic children under 12 years old.

For Chronic Obstructive Pulmonary Disease (COPD):

The usual dose for adults, including the elderly and adolescents 18 years and older is 1 puff in the morning and 1 puff in the evening. This means you need to take a total of 2 puffs (24 micrograms) of Atimos Modulite per day.

If you suffer from more severe COPD your doctor may prescribe 4 puffs per day (48 micrograms), 2 puffs in the morning and 2 puffs in the evening.

4 puffs (48 micrograms) of Atimos is the maximum daily dose and it is important that you do not take more than the total daily dose that your doctor has told you to take.

Do not take more than 2 puffs at any one time.

This product is not suitable for COPD patients under 18 years old.

Do not use Atimos Modulite to treat a sudden attack of breathlessness. You should use a “reliever” inhaler prescribed by your doctor for this purpose, carry this medicine with you at all times.

If you use more Atimos Modulite than you should:

You may notice that your heart is beating faster than usual and that you feel shaky. You may also have a headache, tremor, feeling and being sick (nausea and vomiting) or feel sleepy. Contact your doctor as soon as possible for advice.

If you forget to use Atimos Modulite:

If you forget to use your Atimos Modulite, take it as soon as you remember. If it is almost time for your next dose, do not take the dose you have missed, just take the next dose at the usual time. Do not double the dose.

Do not stop or reduce the dose of Atimos Modulite or any other medicine for your breathing just because you feel better, without talking to your doctor first. It is very important to use these medicines regularly.

Do not increase your dose of Atimos Modulite without talking to your doctor first.

If you feel you are getting breathless or wheezy while using Atimos Modulite, you should continue to use Atimos Modulite but go to see your doctor as soon as possible, you may need additional treatment. Once your asthma is well controlled, your doctor may consider it appropriate to gradually reduce the dose of Atimos Modulite.

Instructions for use:

lt is important that you know how to use your inhaler properly. Your doctor, nurse or pharmacist will show you how to use your inhaler correctly. You must follow their instructions carefully so that you know how, when and how many puffs to inhale. The correct instructions are given in this leaflet. If you are not sure what to do or have problems in inhaling then ask your doctor, nurse or pharmacist for advice.

Testing your inhaler. If your inhaler is new or if it has not been used for 3 days or more, one puff should be released into the air before using it, to make sure that it works.

You should stand or sit in the upright position when using your inhaler.

1. Remove the mouthpiece cover from the inhaler and hold it between the thumb and forefinger as shown.
2. Breathe out as far as is comfortable.
3. Hold the inhaler upright as shown with your thumb on the base below the mouthpiece; place the mouthpiece in your mouth between your teeth and close your lips tightly around it.
4. Breathe in deeply through your mouth and at the same time press down on the top of the inhaler to release a puff.
5. Hold your breath as long as is comfortable, then take the inhaler from your mouth.
6. If you are to take another puff, keep the inhaler upright and wait about half a minute before repeating steps 2 to 5.
7. After use always replace the mouthpiece cover to keep out dust and fluff. Replace firmly and snap into position.

Important: Do not rush steps 2, 3, 4 and 5.

lt is important that you start to breathe in as slowly as possible just before operating the inhaler.

If you see ‘mist‘ coming from the top of the inhaler or the sides of your mouth, Atimos Modulite will not get into your lungs as it should. Take another puff, carefully following the instructions from Step 2 onwards.

If you have weak hands it may be easier to hold the inhaler with both hands. Put the two forefingers on top of the inhaler and both thumbs on the bottom below the mouthpiece.

Tell your doctor, nurse or pharmacist if you have any difficulties.

Cleaning:

It is important to clean your inhaler regularly, at least once or twice a week to ensure that it works properly.

  • Pull the metal canister out of the plastic case of the inhaler and remove the mouthpiece cover.
  • Rinse the plastic case and the mouthpiece cover in warm water.
  • Do not put the metal canister into water.
  • Leave to dry thoroughly in a warm place. Avoid excessive heat.
  • Replace the canister and mouthpiece cover.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines Atimos Modulite can cause side effects although not everybody gets them. Possible side effects are listed below according to their frequency. If you are not sure what the side effects below are, ask your doctor to explain them to you.

If your breathing or wheezing gets worse after using your inhaler stop using Atimos Modulite and tell your doctor immediately. This is caused by narrowing of the airways in your lungs, but it only occurs rarely.

Common side effects which may affect up to 1 in 10 people are: unusually fast heart beat and palpitations, cough, trembling (fine tremor), headache.

Uncommon side effects which may affect fewer than 1 in 100 people are: muscle cramps, pain in muscles, nausea, agitation, restlessness, sleep disorders, dizziness, abnormal or impaired sense of taste, throat irritation, abnormal rapid heart beat, disorders of heart rhythm with increase heart rate, abnormal low levels of potassium in the blood, increase in blood sugar levels, increase in the blood level of insulin, free fatty acids, glycerol and ketones, excessive sweating.

Rare side effects which may affect fewer than 1 in 1,000 people are: missed heartbeats caused by too early contraction of the ventricles of the heart, feeling chest tightness, increase or decrease in blood pressure, wheezing immediately after using the inhaler, severe fall in blood pressure, inflammation of the kidneys, allergic reaction such as itching, rash, bronchospasm, urticaria, swelling of skin and mucous membrane persisting for several days.

Very rare side effects which may affect fewer than 1 in 10,000 people are: worsening of asthma, difficulty breathing, swelling of the hands and/or feet, irregular heartbeat, reduced number of blood platelets, hyperexcitability, abnormal behaviour, hallucinations.

Some side effects, such as tremor, nausea, abnormal or impaired sense of taste, throat irritation, excessive sweating, restlessness, headache, dizziness and muscle cramps, may ease during the course of one to two weeks of continued use of your asthma medication.

Reporting of side effects

If you experience any of the side effects and it causes you distress, is severe or lasts several days, or if you feel unwell or notice anything unusual or a side effect which is not mentioned in this leaflet, you should contact your doctor or pharmacist immediately.

You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Atimos Modulite

  • Keep out of the reach and sight of children.
  • Do not use beyond three months from the date you get the inhaler from your pharmacist and never use after the expiry date which is stated on the carton and label. The expiry date refers to the last day of that month.
  • Do not store the inhaler above 30°C.
  • If the inhaler gets very cold, take the metal canister out of the plastic case and warm it in your hands for a few minutes before use. Never use anything else to warm it up.
  • Warning: The canister contains a pressurised liquid. Do not expose to temperatures higher than 50°C. Do not pierce the canister.
  • Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. Further information

What Atimos Modulite contains:

The active substance of Atimos Modulite is formoterol fumarate dihydrate. Each metered actuation provides 12 micrograms of formoterol fumarate dihydrate. This corresponds to a delivered dose of 10.1 micrograms.

The other ingredients are: hydrochloric acid, ethanol and norflurane (HFA 134a).

What Atimos Modulite looks like and contents of the pack:

Atimos Modulite is a pressurised inhalation solution contained in an aluminium canister with plastic actuator and protective cap.

Each pack contains 1 inhaler which provides 50, 100 or 120 puffs.

Marketing Authorisation Holder:

Chiesi Limited
333 Styal Road
Manchester
M22 5LG
UK

Manufacturer:

Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma
Italy

This medicinal product has been authorised in the member states of the EEA under the following names:

Austria FORADIL

France ATIMOS

Germany ATIFOR CHIESI

Greece FORADIL

Spain BRONCORAL NEO

Belgium ATIMOS

Holland ATIMOS

UK ATIMOS MODULITE

Czech Republic ATIMOS

Slovak Republic ATIMOS

Hungary ATIMOS

Portugal ATIMOS

Slovenia ATIMOS

Poland ATIMOS

Estonia ATIMOS

Latvia ATIMOS

Lithuania ATIMOS

ls this leaflet hard to see or read? Phone 0161 488 5555 for help.

This leaflet was last revised in 09/2015

CP0015/7

Company contact details

Chiesi Limited

Company image
Address

Chiesi Limited, 333 Styal Road, Manchester, M22 5LG

Telephone

0800 009 2329

Telephone

+44 (0) 161 488 5555

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

formoterol fumarate dihydrate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue